Singular Genomics Systems (OMIC): Operatsion rentabellik

Singular Genomics Systems - OMIC emitenti grafik logotipi

Singular Genomics Systems (OMIC) DNK diagnostikasi uchun stol usti analizatorlari va ularga hamroh reagentlarni sotish orqali daromad keltiradi. GURU.Markets ma'lumotlaridagi operatsion foyda marjalari mahalliy cho'qqini ko'rsatmoqda, bunda -3488.50 belgisi ushbu parametrni tavsiflaydi. Operatsion rentabellikning barqarorligi optika yetkazib beruvchilarining diversifikatsiyasi bilan ta'minlanmoqda. Biroq, asbob-uskunalarning kichik partiyali ishlab chiqarilishi leveraj effektini cheklab, ushbu texnikalarning birlik xarajatlarini yuqori darajada saqlab qolmoqda.

OMIC: singulargenomics.com Operatsion faoliyat rentabelligi 04.07.2022 - 01.03.2025

OMIC (Singular Genomics): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:OMIC, Singular Genomics Corp
singulargenomics.com asosiy tovari

Singular Genomics Systems (OMIC) biznesi uchun fundamental tayanch darajasini aniqlash maqsadida, operatsion foyda marjasi orqali monopollar bilan raqobatning samaradorligini baholash zarurdir. Ushbu grafik asosiy operatsiyalardan olingan foydaning umumiy daromadga nisbatini o'lchaydi va ochiq arxitekturali sekvenslash tizimlarining soliqlar va foizlardan oldin pul oqimini yaratish qobiliyatini aks ettiradi, bu esa aktivning uzoq muddatli barqarorligini belgilaydi.

Raqobatchilar tahlili

Sotuvning operatsion marjasi TEM|QGEN - Operatsion foyda bo'yicha marjinallik|Operatsion marja IONS|RGEN - Sotuvning operatsion rentabelligi|Operatsion rentabellik Avidity RNA|Operatsion marja CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operatsion marja|Ultragenyx Pharma (RARE) - Sotuvning operatsion marjasi|beamtx.com (BEAM) - Operatsion rentabellik|SRPT: Operatsion foyda koeffitsiyenti|Sotuvning operatsion marjasi TWST|TXG - Operatsion foyda bo'yicha marjinallik|Operatsion marja NTLA|Operatsion faoliyat rentabelligi Stoke Therapeutics|Operatsion rentabellik BioLife Solutions BLFS|Wave Life Sciences (WVE) - Sotuvning operatsion rentabelligi|Maze Therapeutics, Inc. - Operatsion marja|Operatsion faoliyat rentabelligi Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operatsion rentabellik|TSHA: Operatsion foyda koeffitsiyenti|Operatsion rentabellik uniQure Pharma|MGTX - Operatsion foyda bo'yicha marjinallik|Operatsion marja RGNX|Operatsion rentabellik SLDB (Solid Biosciences)|Ocugen Corp - Sotuvning operatsion marjasi|PACB: Operatsion foyda bo'yicha sotuv rentabelligi|benitec.com - Operatsion marja|DSGN - Operatsion marja|RCKT: Operatsion marja|FDMT (4D Molecular Therapeutics Inc) - Operatsion rentabellik|Sotuvning operatsion marjasi LXEO|Operatsion rentabellik KRRO|Operatsion marja EDIT|SLN - Sotuvning operatsion rentabelligi|Operatsion marja PRQR (ProQR)|CDXS - Sotuvning operatsion marjasi|Sangamo Therapeutics Inc. - Operatsion marja|NAUT - Operatsion marja|MGX: Operatsion marja|Sotuvning operatsion marjasi Precision BioSciences, Inc.|GBIO (Generation Bio) - Operatsion marja|Boundless Bio Inc. (BOLD) - Operatsion faoliyat rentabelligi|Sotuvning operatsion marjasi XCUR (exicuretx.com)|Imunon Inc - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja PHIO (Phio Pharmaceuticals Corp)|Operatsion foyda normasi MBIO|RNAZ - Operatsion rentabellik|Operatsion foyda normasi BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operatsion rentabellik|Bluebird Bio - Operatsion foyda normasi|IPA (ImmunoPrecise Antibodies Ltd) - Operatsion marja|Sotuvning operatsion rentabelligi Omega Therapeutics, Inc. OMGA|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik